Atrial-specific drugs: The way to treat atrial fibrillation?

被引：21
|
作者：
Vos, MA [1 ]
机构：
[1] UMCU, NL-3584 CM Utrecht, Netherlands
来源：
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2004年 / 15卷 / 12期
关键词：
D O I：
10.1046/j.1540-8167.2004.04569.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1451 / 1452
页数：2
相关论文
共 50 条
  • [1] Doxapram is a promising new antiarrhythmic drug for an atrial-specific therapy of atrial fibrillation
    Schmidt, C.
    Wiedmann, F.
    Beyersdorf, C.
    Zhao, Z.
    El-Battrawy, I.
    Kraft, M.
    Lang, S.
    Szabo, G.
    Karck, M.
    Zhou, X.
    Borggrefe, M.
    Thomas, D.
    Haefeli, W. E.
    Decher, N.
    Katus, H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 670 - 670
  • [2] Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation
    Hulsurkar, Mohit M.
    Lahiri, Satadru K.
    Moore, Oliver
    Moreira, Lucia M.
    Abu-Taha, Issam
    Kamler, Markus
    Dobrev, Dobromir
    Nattel, Stanley
    Reilly, Svetlana
    Wehrens, Xander H. T.
    CIRCULATION, 2021, 144 (11) : 909 - 912
  • [3] MICROPEROXISOMES MASQUERADING AS ATRIAL-SPECIFIC GRANULES
    THERON, JJ
    STEINMANN, C
    LOURENS, N
    MEDICAL SCIENCE RESEARCH, 1995, 23 (01): : 23 - 24
  • [4] A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation
    Nathan Orr
    Rima Arnaout
    Lorne J. Gula
    Danna A. Spears
    Peter Leong-Sit
    Qiuju Li
    Wadea Tarhuni
    Sven Reischauer
    Vijay S. Chauhan
    Matthew Borkovich
    Shaheen Uppal
    Arnon Adler
    Shaun R. Coughlin
    Didier Y. R. Stainier
    Michael H. Gollob
    Nature Communications, 7
  • [5] ABC of atrial fibrillation - Drugs for atrial fibrillation
    Lip, GYH
    Watson, RDS
    Singh, SP
    BRITISH MEDICAL JOURNAL, 1995, 311 (7020): : 1631 - 1634
  • [6] A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation
    Orr, Nathan
    Arnaout, Rima
    Gula, Lorne J.
    Spears, Danna A.
    Leong-Sit, Peter
    Li, Qiuju
    Tarhuni, Wadea
    Reischauer, Sven
    Chauhan, Vijay S.
    Borkovich, Matthew
    Uppal, Shaheen
    Adler, Arnon
    Coughlin, Shaun R.
    Stainier, Didier Y. R.
    Gollob, Michael H.
    NATURE COMMUNICATIONS, 2016, 7
  • [7] MAIN FORMS OF IMMUNOREACTIVE CARDIONATRIN IN ATRIAL EXTRACTS AND IN ATRIAL-SPECIFIC GRANULES
    FLYNN, TG
    DEBOLD, AJ
    DEBOLD, ML
    DAVIES, PL
    KENNEDY, BP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1985, 13 (06) : 1141 - 1141
  • [8] Antiarrhythmic Drugs for Atrial Fibrillation in the Real World Trick or Treat
    Naccarelli, Gerald V.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (02) : 242 - 244
  • [9] Bone morphogenetic protein 10-a novel atrial-specific biomarker to predict adverse outcomes in patients with atrial fibrillation
    Hennings, E.
    Blum, S.
    Aeschbacher, S.
    Coslovsky, M.
    Knecht, S.
    Eken, C.
    Lischer, M.
    Paladini, R.
    Krisai, P.
    Reichlin, T.
    Rodondi, N.
    Beer, J. H.
    Amman, P.
    Conte, G.
    De Perna, ML.
    Kobza, R.
    Blum, M. R.
    Bossard, M.
    Kastner, P.
    Ziegler, A.
    Muller, C.
    Zuern, C. S.
    Bonati, L. H.
    Conen, D.
    Kuhne, M.
    Osswald, S.
    SWISS MEDICAL WEEKLY, 2022, 152 : 50S - 51S
  • [10] Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation
    Christophersen, Ingrid E.
    Olesen, Morten S.
    Liang, Bo
    Andersen, Martin N.
    Larsen, Anders P.
    Nielsen, Jonas B.
    Haunso, Stig
    Olesen, Soren-Peter
    Tveit, Arnljot
    Svendsen, Jesper H.
    Schmitt, Nicole
    EUROPEAN HEART JOURNAL, 2013, 34 (20) : 1517 - 1525
12345